2010
DOI: 10.3892/mmr.2010.407
|View full text |Cite
|
Sign up to set email alerts
|

Screening for differential methylation status in fetal myocardial tissue samples with ventricular septal defects by promoter methylation microarrays

Abstract: Abstract.To identify and provide a global assessment of dna methylation in fetal ventricular septal defect (VSd), genomic dna extracted from fetal myocardial tissue samples with VSd (n=21) and from normal fetal myocardial tissue samples (n=15) was analyzed for gene methylation using array-based technology. Furthermore, the Kiaa0310, raB43, SiVa1 and ndrG2 genes were randomly selected for validation analysis using methylation-specific PCR. Our results revealed that 70 and 85 genes were regulated by hypermethyla… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…Although gene mutations are potential causes for the development of CHD [3], various environmental factors that affect mother during the pregnancy also play an important role in promoting and developing of CHD [4]. For example, epigenetic modifications and gene methylation changes in fetus during pregnancy can affect gene expression levels during the development [5-7]. Aberrant methylation in the promoter region of genes can inhibit gene transcription activities by preventing the binding of transcription factor from the target genes, which is one of the potential causes of gene silence and disease [8].…”
Section: Introductionmentioning
confidence: 99%
“…Although gene mutations are potential causes for the development of CHD [3], various environmental factors that affect mother during the pregnancy also play an important role in promoting and developing of CHD [4]. For example, epigenetic modifications and gene methylation changes in fetus during pregnancy can affect gene expression levels during the development [5-7]. Aberrant methylation in the promoter region of genes can inhibit gene transcription activities by preventing the binding of transcription factor from the target genes, which is one of the potential causes of gene silence and disease [8].…”
Section: Introductionmentioning
confidence: 99%
“…Previous work exploring methylation patterns in cardiac tissue from fetuses with VSD (vs. controls) showed hypomethylation of 2 apoptosis-related genes (SIVA1 and MDM2) among only the VSD samples (46). However, there were also genes that were hypermethylated in case samples.…”
Section: Discussionmentioning
confidence: 90%
“…This process is heritable as well as tissue-specific and plays a major role in various physiological processes linked to cardiogenesis such as cardiomyocyte development, maturation and cardiac regeneration [9,10]. Aberrant changes in methylation profiles are associated with cardiovascular diseases (CVDs) such as ventricular septal defects, tetralogy of Fallot, atherosclerosis as well as other CVDs that lead to end-stage heart failure [11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%